Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  A M A Archives of Ophthalmology

• Publication date

  2001-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHOPHT.119.10.1518PMID 11594954
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of a single intravitreal injection of 5-fluorouracil in vitrectomy cases

  2005cited by this paper
• Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma

  1999cited by this paper
• Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma.

  1998cited by this paper
• Subconjunctival carboplatin therapy and cryotherapy in the treatment of transgenic murine retinoblastoma.

  1997cited by this paper
• Finite element modeling of drug distribution in the vitreous humor of the rabbit eye

  1997cited by this paper
• Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma.

  1997cited by this paper
• Glucocorticoid-induced long-term remission in primary cerebral lymphoma: case report and review of the literature

  1997cited by this paper
• Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients

  1996cited by this paper
• Primary central nervous system lymphoma.

  1995cited by this paper
• NATIONAL CANCER INSTITUTE

  1993cited by this paper
• Evaluation of the retinal toxicity and pharmacokinetics of dexamethasone after intravitreal injection.

  1992cited by this paper
• The influence of drug interval on the effect of methotrexate and fluorouracil in the treatment of advanced colorectal cancer.

  1991cited by this paper
• Intravitreal dexamethasone following vitreous surgery

  1991cited by this paper
• Toxicity of high-dose intravitreal dexamethasone

  1991cited by this paper
• Effects of fluorouracil and fluorouridine on protein synthesis in rabbit retina.

  1990cited by this paper
• Effect of subconjunctivally administered antineoplastics on experimentally induced intraocular malignant tumour.

  1989cited by this paper
• Primary central nervous system lymphoma.

  1988cited by this paper
• Fluorouracil therapy of intraocular Greene melanoma in the rabbit.

  1988cited by this paper
• Central nervous system leukemia.

  1988cited by this paper
• Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma.

  1987cited by this paper
• Sequential combination chemotherapy of high-grade non-Hodgkin's lymphoma with 5-fluorouracil, methotrexate, cytosine-arabinoside, cyclophosphamide, doxorubicin, vincristine, and prednisone (F-MACHOP).

  1987cited by this paper
• Effects of selected repeated intravitreal chemotherapeutic agents

  1985cited by this paper
• Clearance of intravitreal fluorouracil. Normal and aphakic vitrectomized eyes.

  1985cited by this paper
• A phase I and pharmacology study of continuous‐infusion low‐dose methotrexate administration

  1985cited by this paper
• Sequential infusions of methotrexate and 5-fluorouracil in advanced cancer: pharmacology, toxicity, and response.

  1985cited by this paper
• Glucocorticoid receptors and steroid sensitivity in normal and neoplastic human lymphoid tissues: a review.

  1984cited by this paper
• Evaluation of intravitreal 5-fluorouracil, vincristine, VP 16, doxorubicin, and thiotepa in primate eyes.

  1984cited by this paper
• 5-fluorouracil: new applications in complicated retinal detachment for an established antimetabolite.

  1984cited by this paper
• Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy.

  1983cited by this paper
• Combined local chemotherapy for a spontaneously occurring intraocular tumour in a cat.

  1983cited by this paper
• Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen.

  1983cited by this paper
• Steroid‐induced remissions in CNS lymphoma

  1982cited by this paper
• Fluorouracil for the treatment of massive periretinal proliferation.

  1982cited by this paper
• Optimal schedule of methotrexate and 5-fluorouracil in human breast cancer.

  1982cited by this paper
• Optimal Scheduling of Methotrexate and 5-Fluorouracil in Human Breast Cancer

  1982cited by this paper
• Experimental combined systemic and local chemotherapy for intraocular malignancy.

  1980cited by this paper
• Variations in cellular sensitivity to glucocorticoids: observations and mechanisms.

  1979cited by this paper
• An interophthalmic communicating artery as explanation for the consensual irritative response of the rabbit eye.

  1979cited by this paper
• Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: explanation for drug synergism.

  1979cited by this paper
• New dose-time relationships of folate antagonists to sustain inhibition of human lymphoblasts and leukemic cells in vitro.

  1979cited by this paper
• "Concentration x time" methotrexate via a subcutaneous reservoir: a less toxic regimen for intraventricular chemotherapy of central nervous system neoplasms.

  1978cited by this paper
• Glucocorticoid Receptors in Lymphoma Cells in Culture: Relationship to Glucocorticoid Killing Activity

  1971cited by this paper
• S-phase cells of rapidly growing and resting populations. Differences in response to methotrexate.

  1969cited by this paper
• Inhibitory effects of hydrocortisone upon the phytohemagglutinin-induced RNA-synthesis in human lymphocytes.

  1968cited by this paper
• United States Pharmacopeia

  1955cited by this paper

• An intraocular lens coated with polycaprolactone and methotrexate as a slow-release system for prophylaxis of posterior capsule opacification in-vitro.

  2025cites this paper
• Methotrexate‐Loaded Liposomal Formulation Enables 6‐Week Sustained Intraocular Therapeutic Drug Release in a Porcine Model

  2025cites this paper
• Dual Application of Methotrexate Improves Functional and Anatomical Outcomes in Diabetic Tractional Retinal Detachment.

  2025cites this paper
• Crystalline Precipitates Secondary to Intravitreal Methotrexate.

  2024cites this paper
• THE ROLE OF INTRAVITREAL METHOTREXATE AS AN ADJUNCT TO LOCAL OR SYSTEMIC CORTICOSTEROIDS IN VITRECTOMY FOR RHEGMATOGENOUS RETINAL DETACHMENT AND CHOROIDAL DETACHMENT

  2024influential citation
• Clinical Therapeutics for Proliferative Vitreoretinopathy in Retinal Detachment.

  2024cites this paper
• Conditions for modifying intraocular lenses as drug carriers for methotrexate using poly (lactic-co-glycolic acid)

  2024cites this paper
• Application of Hydrogels in the Device of Ophthalmic Iontophoresis: Theory, Developments and Perspectives

  2023cites this paper
• Designing Covalent Organic Framework-based Light-driven Microswimmers towards Intraocular Theranostic Applications

  2023cites this paper
• Designing Covalent Organic Framework‐Based Light‐Driven Microswimmers toward Therapeutic Applications

  2023cites this paper
• Inhibition of proliferative vitreoretinopathy by a newly developed methotrexate loaded drug carrier in vitro.

  2022cites this paper
• A comprehensive review of intravitreal immunosuppressants and biologicals used in ophthalmology

  2022cites this paper
• Intraocular Methotrexate for the Treatment and Prevention of Proliferative Vitreoretinopathy: A Review

  2022cites this paper
• Intravitreal methotrexate infusion for prophylaxis of proliferative vitreoretinopathy after pars plana vitrectomy for rhegmatogenous retinal detachment

  2022cites this paper
• Non-invasive evaluation of toxicity in vitreoretinal domain following insertion of sustained release methotrexate micro-implant.

  2021cites this paper
• Permeability of the Retina and RPE-Choroid-Sclera to Three Ophthalmic Drugs and the Associated Factors

  2021cites this paper
• Electrophysiological Monitoring of Focal and Entire Retinal Function during Treatment with Intravitreal Methotrexate for Intraocular Lymphoma

  2021cites this paper
• Experimental evaluation of safety and efficacy of plasma-treated poly-ε-caprolactone membrane as a substitute for human amniotic membrane in treating corneal epithelial defects in rabbit eyes

  2021cites this paper
• Anatomical and Functional Outcomes of Vitrectomy with/without Intravitreal Methotrexate Infusion for Management of Proliferative Vitreoretinopathy Secondary to Rhegmatogenous Retinal Detachment

  2021cites this paper
• Adjunctive serial post-operative intravitreal methotrexate injections in the management of advanced proliferative vitreoretinopathy

  2021cites this paper
• Pharmacokinetics and Toxicity Evaluation of a PLGA and Chitosan-Based Micro-Implant for Sustained Release of Methotrexate in Rabbit Vitreous

  2021influential citation
• Masquerade Syndromes

  2020cites this paper
• A Prediction Model for the Intraocular Pharmacokinetics of Intravitreally Injected Drugs Based on Molecular Physicochemical Properties

  2019cites this paper
• Local Drug Delivery for Noninfectious Uveitis

  2019cites this paper
• Use of the permitted daily exposure (PDE) concept for contaminants of intravitreal (IVT) drugs in multipurpose manufacturing facilities

  2019cites this paper
• Treatment of Non-infectious Uveitis

  2019cites this paper
• Improved design and characterization of PLGA/PLA‐coated Chitosan based micro‐implants for controlled release of hydrophilic drugs

  2018cites this paper
• Intravitreal injection of methotrexate in persistent diabetic macular edema: a 6-month follow-up study

  2016cites this paper
• Ultrasonographical assessment of implanted biodegradable device for long-term slow release of methotrexate into the vitreous.

  2016influential citation
• Noninvasive Electroretinography Assessment of Intravitreal Sustained-Release Methotrexate Microimplants in Rabbit Eyes

  2016influential citation
• Effect of Intravitreal Injection of Methotrexate on Human Corneal Endothelial Cells

  2016cites this paper
• Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injection

  2016cites this paper
• Ocular and systemic pharmacokinetic models for drug discovery and development

  2015cites this paper
• Who Is Who in Primary Vitreoretinal Lymphoma?

  2015cites this paper
• Biodegradable chitosan and polylactic acid-based intraocular micro-implant for sustained release of methotrexate into vitreous: analysis of pharmacokinetics and toxicity in rabbit eyes

  2015cites this paper
• Intravitreal clearance and volume of distribution of compounds in rabbits: In silico prediction and pharmacokinetic simulations for drug development.

  2015cites this paper
• Local chemotherapeutic agents for the treatment of ocular malignancies.

  2014cites this paper
• Ocular and Adnexal T-Cell Lymphoma

  2014cites this paper
• Development of chitosan and polylactic acid based methotrexate intravitreal micro-implants to treat primary intraocular lymphoma: an in vitro study.

  2014cites this paper
• IV.E. Principles and Practice of Intravitreal Application of Drugs

  2014cites this paper
• Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.

  2013cites this paper
• Intravitreal injection of methotrexate in an experimental rabbit model: Determination of ultrastructural changes

  2013cites this paper
• Simulating Intravitreal Injections in Anatomically Accurate Models for Rabbit, Monkey, and Human Eyes

  2012cites this paper
• Experimental models of autoimmune inflammatory ocular diseases.

  2012cites this paper
• Experimental models of autoimmune inflammatory ocular diseases Modelos experimentais para o estudo de doenças inflamatórias oculares autoimunes

  2012cites this paper
• Retina-Choroid-Sclera Permeability for Ophthalmic Drugs in the Vitreous to Blood Direction: Quantitative Assessment

  2012cites this paper
• INTRAVITREAL METHOTREXATE IN THE MANAGEMENT OF PRESUMED TUBERCULOUS SERPIGINOUS-LIKE CHOROIDITIS

  2012cites this paper
• Prediction of the Vitreal Half-Life of Small Molecular Drug-Like Compounds

  2012cites this paper
• Repeated IL-10 measurement in aqueous humor and OCT imaging are valuable tools to monitor intraocular lymphoma treated with intravitreal injections of methotrexate

  2012influential citation
• Retinal toxicity after repeated intravitreal carboplatin injection into rabbit eyes.

  2012cites this paper
• Intravitreal injection of methotrexate in an experimental rabbit model: Determination of pharmacokinetics

  2011cites this paper
• Intraocular T-cell Lymphoma due to Mycosis Fungoides and Response to Intravitreal Methotrexate

  2011cites this paper
• Toxicity of a Biodegradable Microneedle Implant Loaded with Methotrexate as a Sustained Release Device in Normal Rabbit Eye: A Pilot Study

  2011cites this paper
• Investigation of Kinetics of Methotrexate for Therapeutic Treatment of Intraocular Lymphoma

  2010cites this paper
• Intravitreal Carboplatin Concentration and area under Concentration versus Time Curve after Intravitreal and Periocular Delivery

  2010cites this paper
• Vitreous VEGF clearance is increased after vitrectomy.

  2010cites this paper
• Testicular lymphoma, intraocular (Vitreoretinal) lymphoma, and brain lymphoma: Involvement of three immunoprivileged sites in one patient

  2010cites this paper
• CHAPTER 15 – Retina and ocular toxicity to ocular application of drugs

  2010cites this paper
• What do healthcare providers ask their patients with immune thrombocytopenia?

  2010cites this paper
• Retinal and Ocular Toxicity in Ocular Application of Drugs and Chemicals – Part I: Animal Models and Toxicity Assays

  2010cites this paper
• Low CD49d expression and long telomere identify a chronic lymphocytic leukemia subset with highly favourable outcome

  2010cites this paper
• Retinal and Ocular Toxicity in Ocular Application of Drugs and Chemicals – Part II: Retinal Toxicity of Current and New Drugs

  2010cites this paper
• Rituximab for intraocular lymphoma.

  2009cites this paper
• Prediction of Vitreal Half-Life Based on Drug Physicochemical Properties: Quantitative Structure–Pharmacokinetic Relationships (QSPKR)

  2009cites this paper
• A Case of Primary Intraocular Lymphoma Treated by Intravitreal Methotrexate

  2009cites this paper
• Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema.

  2009cites this paper
• Evaluation of the pro-inflammatory potential of nanostructured drug carriers in knee-joints of rats: effect on nociception, edema, and cell migration.

  2009cites this paper
• INTRAVITREAL INJECTION OF THERAPEUTIC AGENTS

  2009cites this paper
• Intravitreal methotrexate in therapeutically resistant exudative age‐related macular degeneration

  2009cites this paper
• Clinical Review: Treatment of Vitreoretinal Lymphoma

  2009cites this paper
• Hydroxyurea in children with sickle cell disease: Practice patterns and barriers to utilization

  2009cites this paper
• THE SAFETY OF INTRAOCULAR METHOTREXATE IN SILICONE-FILLED EYES

  2008cites this paper
• Methotrexate Delivery to the Eye Using Transscleral Hydrogel Iontophoresis

  2007cites this paper
• Comparison of 2-Methoxyestradiol and Methotrexate Effects on Non-Hodgkin's B-Cell Lymphoma

  2007cites this paper
• SAFETY AND PHARMACOKINETICS OF A PRESERVATIVE-FREE TRIAMCINOLONE ACETONIDE FORMULATION FOR INTRAVITREAL ADMINISTRATION

  2006cites this paper
• Ocular manifestations and treatment of central nervous system lymphomas.

  2006cites this paper
• A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide.

  2006cites this paper
• Ocular Barriers to Transscleral Drug Delivery and Pharmacokinetics of an Episcleral Implant

  2006cites this paper
• Methotrexate reduces the complications of endophthalmitis resulting from intravitreal injection compared with dexamethasone in a rabbit model.

  2006cites this paper
• Intraocular methotrexate in ocular diseases other than primary central nervous system lymphoma.

  2006cites this paper
• Intraocular injection of folate antagonist methotrexate induces neuronal differentiation of embryonic stem cells transplanted in the adult mouse retina.

  2006cites this paper
• An Asian Patient with Intraocular Lymphoma Treated by Intravitreal Methotrexate

  2006cites this paper
• Management of primary intraocular lymphoma

  2005cites this paper
• Ocular lymphoma in two cases.

  2004cites this paper
• [Intraocular non-Hodgkin's lymphoma and its therapy-- a case series of ten patients].

  2004cites this paper
• Pseudouveitis: A Clue to the Diagnosis of Primary Central Nervous System Lymphoma in Immunocompetent Patients

  2004cites this paper
• Reduced full-field electroretinogram (ERG) in a patient treated with methotrexate.

  2004influential citation
• Das intraokulare Non-Hodgkin-Lymphom und seine Therapie - eine Fallserie mit 10 Patienten

  2004cites this paper
• [Intravitreal chemotherapy for intraocular lymphoma].

  2003cites this paper
• Das therapeutische Prinzip

  2003cites this paper
• Intravitreale Chemotherapie bei okulozerebralem Lymphom

  2003cites this paper
• High-Dose Methotrexate for Intraocular Lymphoma 1

  2003cites this paper
• Primary ocular lymphoma: clinical features, diagnosis, and treatment.

  2003cites this paper
• High-dose methotrexate for intraocular lymphoma.

  2003cites this paper
• Local methotrexate and dexamethasone phosphate for the treatment of recurrent primary intraocular lymphoma.

  2002cites this paper
• Primary central nervous system (CNS) lymphoma in immunocompetent patients

  2002cites this paper
• Safety and pharmacokinetics of intravitreal 2-methoxyestradiol implants in normal rabbit and pharmacodynamics in a rat model of choroidal neovascularization.

  2002cites this paper
• Intraocular lymphoma

  2002cites this paper
• Methotrexate Intravitreal Injection During Rhegmatogenous Methotrexate Intravitreal Injection During Rhegmatogenous Retinal Detachment Repair Surgery to Prevent Proliferative Retinal Detachment Repair Surgery to Prevent Proliferative Vitreoretinopathy

  year unknowncites this paper